
Profitability, historical returns, and peer comparisons.
According to Abpro Corporation’s latest financial reports and current stock price. The company's current ROE is -35.79%. This represents a change of -294.57% compared to the average of 18.39% of the last 4 quarters.
The mean historical ROE of Abpro Corporation over the last ten years is -57.38%. The current -35.79% ROE has changed -37.64% with respect to the historical average. Over the past ten years (40 quarters), ABP's ROE was at its highest in in the March 2023 quarter at 2.01%. The ROE was at its lowest in in the March 2024 quarter at -5.90%.
Average
-57.38%
Median
22.57%
Minimum
-584.26%
Maximum
55.01%
Discovering the peaks and valleys of Abpro Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 241.63%
Maximum Annual ROE = 55.01%
Minimum Annual Increase = -1162.18%
Minimum Annual ROE = -584.26%
| Year | ROE | Change |
|---|---|---|
| 2025 | 0% | -100.00% |
| 2024 | 46.67% | 241.63% |
| 2023 | 13.66% | -39.46% |
| 2022 | 22.57% | -103.86% |
| 2021 | -584.26% | -1162.18% |
| 2017 | 55.01% | 23.15% |
The current ROE of Abpro Corporation (ABP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.11%
5-year avg
-100.27%
10-year avg
-57.38%
Abpro Corporation’s ROE is greater than Aptorum Group Limited (-5.94%), greater than Marker Therapeutics, Inc. (-56.96%), less than AEON Biopharma, Inc. (204.18%), greater than Cingulate Inc. (-238.41%), greater than Mustang Bio, Inc. (-34.23%), greater than Cellectar Biosciences, Inc. (-165.71%), greater than Bolt Biotherapeutics, Inc. (-126.23%), less than Evogene Ltd. (761.97%), less than Lyra Therapeutics, Inc. (455.31%), greater than Sensei Biotherapeutics, Inc. (-192.76%),
| Company | ROE | Market cap |
|---|---|---|
| -5.94% | $5.24M | |
| -56.96% | $15.06M | |
| 204.18% | $14.44M | |
| -238.41% | $71.69M | |
| -34.23% | $2.83M | |
| -165.71% | $11.53M | |
| -126.23% | $12.14M | |
| 761.97% | $3.22M | |
| 455.31% | $53.25K | |
| -192.76% | $18.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abpro Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abpro Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Abpro Corporation's ROE?
How is the ROE calculated for Abpro Corporation (ABP)?
What is the highest ROE for Abpro Corporation (ABP)?
What is the 3-year average ROE for Abpro Corporation (ABP)?
What is the 5-year average ROE for Abpro Corporation (ABP)?
How does the current ROE for Abpro Corporation (ABP) compare to its historical average?